100 related articles for article (PubMed ID: 22136855)
1. Intranasal hypocretin-1: making sense of scents?
Lammers GJ
Sleep Med; 2011 Dec; 12(10):939-40. PubMed ID: 22136855
[No Abstract] [Full Text] [Related]
2. Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy.
Baier PC; Hallschmid M; Seeck-Hirschner M; Weinhold SL; Burkert S; Diessner N; Göder R; Aldenhoff JB; Hinze-Selch D
Sleep Med; 2011 Dec; 12(10):941-6. PubMed ID: 22036605
[TBL] [Abstract][Full Text] [Related]
3. The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy.
Weinhold SL; Seeck-Hirschner M; Nowak A; Hallschmid M; Göder R; Baier PC
Behav Brain Res; 2014 Apr; 262():8-13. PubMed ID: 24406723
[TBL] [Abstract][Full Text] [Related]
4. The effect of hypocretin replacement therapy in a 3-year-old Weimaraner with narcolepsy.
Schatzberg SJ; Cutter-Schatzberg K; Nydam D; Barrett J; Penn R; Flanders J; deLahunta A; Lin L; Mignot E
J Vet Intern Med; 2004; 18(4):586-8. PubMed ID: 15320603
[No Abstract] [Full Text] [Related]
5. The injection of hypocretin-1 into the nucleus pontis oralis induces either active sleep or wakefulness depending on the behavioral state when it is administered.
Xi M; Chase MH
Sleep; 2010 Sep; 33(9):1236-43. PubMed ID: 20857871
[TBL] [Abstract][Full Text] [Related]
6. Sleep-wakefulness effects after microinjections of hypocretin 1 (orexin A) in cholinoceptive areas of the cat oral pontine tegmentum.
Moreno-Balandrán E; Garzón M; Bódalo C; Reinoso-Suárez F; de Andrés I
Eur J Neurosci; 2008 Jul; 28(2):331-41. PubMed ID: 18702704
[TBL] [Abstract][Full Text] [Related]
7. Pontine reticular formation (PnO) administration of hypocretin-1 increases PnO GABA levels and wakefulness.
Watson CJ; Soto-Calderon H; Lydic R; Baghdoyan HA
Sleep; 2008 Apr; 31(4):453-64. PubMed ID: 18457232
[TBL] [Abstract][Full Text] [Related]
8. [Hypocretins: involvement in the regulation of sleep-wakefulness cycle and pathogenesis of narcolepsy].
Berezińska M; Zawilska JB
Postepy Hig Med Dosw (Online); 2007; 61():1-12. PubMed ID: 17245312
[TBL] [Abstract][Full Text] [Related]
9. Narcolepsy: pathophysiology and pharmacology.
Nishino S
J Clin Psychiatry; 2007; 68 Suppl 13():9-15. PubMed ID: 18078360
[TBL] [Abstract][Full Text] [Related]
10. The hypocretins and sleep.
de Lecea L; Sutcliffe JG
FEBS J; 2005 Nov; 272(22):5675-88. PubMed ID: 16279933
[TBL] [Abstract][Full Text] [Related]
11. Narcolepsy and depression and the neurobiology of gammahydroxybutyrate.
Mamelak M
Prog Neurobiol; 2009 Oct; 89(2):193-219. PubMed ID: 19654034
[TBL] [Abstract][Full Text] [Related]
12. [The neurotransmitter, hypocretin. An overview].
Baumann C; Bassetti C
Nervenarzt; 2004 Apr; 75(4):317-23. PubMed ID: 15088087
[TBL] [Abstract][Full Text] [Related]
13. Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system.
Dhuria SV; Hanson LR; Frey WH
J Pharm Sci; 2009 Jul; 98(7):2501-15. PubMed ID: 19025760
[TBL] [Abstract][Full Text] [Related]
14. Induction of active (REM) sleep and motor inhibition by hypocretin in the nucleus pontis oralis of the cat.
Xi MC; Fung SJ; Yamuy J; Morales FR; Chase MH
J Neurophysiol; 2002 Jun; 87(6):2880-8. PubMed ID: 12037191
[TBL] [Abstract][Full Text] [Related]
15. Awakening to the psychopharmacology of sleep and arousal: novel neurotransmitters and wake-promoting drugs.
Stahl SM
J Clin Psychiatry; 2002 Jun; 63(6):467-8. PubMed ID: 12088156
[TBL] [Abstract][Full Text] [Related]
16. [The neurophysiology of cataplexy].
Mayer G
Nervenarzt; 2005 Dec; 76(12):1464, 1466-9. PubMed ID: 16028082
[TBL] [Abstract][Full Text] [Related]
17. [Narcolepsy: a new perspective on diagnosis and treatment].
Fronczek R; van der Zande WL; van Dijk JG; Overeem S; Lammers GJ
Ned Tijdschr Geneeskd; 2007 Apr; 151(15):856-61. PubMed ID: 17472116
[TBL] [Abstract][Full Text] [Related]
18. The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding.
Sutcliffe JG; de Lecea L
J Neurosci Res; 2000 Oct; 62(2):161-8. PubMed ID: 11020209
[TBL] [Abstract][Full Text] [Related]
19. Orexins cause epileptic activity.
Erken HA; Erken G; Genç O; Kortunay S; Sahiner M; Turgut G; Turgut S
Peptides; 2012 Sep; 37(1):161-4. PubMed ID: 22771311
[TBL] [Abstract][Full Text] [Related]
20. Roles of the hypocretin/orexins in the regulation of sleep and wakefulness.
Terao A; Haruyama T; Kimura K
Jpn J Vet Res; 2008 Jan; 55(2-3):75-83. PubMed ID: 18318109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
